NYSE:CDAYCeridian HCM Stock Price, Forecast & News

Ceridian HCM's stock was trading at $56.63 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, CDAY shares have increased by 21.6% and is now trading at $68.87. View which stocks have been most impacted by Coronavirus.

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ceridian HCM in the last year. There are currently 2 sell ratings, 6 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Ceridian HCM.

Ceridian HCM is scheduled to release its next quarterly earnings announcement on Tuesday, August 4th 2020. View our earnings forecast for Ceridian HCM.

Ceridian HCM Holding Inc (NYSE:CDAY) posted its quarterly earnings data on Wednesday, May, 6th. The company reported $0.15 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.12 by $0.03. The company had revenue of $222.70 million for the quarter, compared to analyst estimates of $218.42 million. Ceridian HCM had a return on equity of 1.80% and a net margin of 9.03%. The company's revenue for the quarter was up 9.3% compared to the same quarter last year. During the same period last year, the business earned $0.14 earnings per share. View Ceridian HCM's earnings history.

15 equities research analysts have issued 12 month price targets for Ceridian HCM's shares. Their forecasts range from $45.00 to $84.00. On average, they anticipate Ceridian HCM's stock price to reach $65.06 in the next twelve months. This suggests that the stock has a possible downside of 5.5%. View analysts' price targets for Ceridian HCM.

News articles about CDAY stock have trended very negative recently, according to InfoTrie. InfoTrie identifies positive and negative media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Ceridian HCM earned a news impact score of -3.5 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 3.0 out of 10, indicating that recent media coverage is unlikely to have an impact on the stock's share price in the next few days. View the latest news aboutCeridian HCM.

Ceridian HCM saw a decline in short interest during the month of May. As of May 15th, there was short interest totaling 11,640,000 shares, a decline of 13.1% from the April 30th total of 13,390,000 shares. Based on an average daily volume of 1,520,000 shares, the days-to-cover ratio is presently 7.7 days. Approximately 10.6% of the shares of the stock are sold short. View Ceridian HCM's Current Options Chain.

Some companies that are related to Ceridian HCM include Square (SQ), Electronic Arts (EA), Veeva Systems (VEEV), Splunk (SPLK), Twilio (TWLO), Synopsys (SNPS), Cadence Design Systems (CDNS), Okta (OKTA), Docusign (DOCU), ANSYS (ANSS), Atlassian (TEAM), Datadog (DDOG), Citrix Systems (CTXS), Paycom Software (PAYC) and Crowdstrike (CRWD). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Ceridian HCM investors own include Workday (WDAY), Alibaba Group (BABA), NVIDIA (NVDA), Adobe (ADBE), Paycom Software (PAYC), Advanced Micro Devices (AMD), Costco Wholesale (COST), Alteryx (AYX), Shopify (SHOP) and Tesla (TSLA).

(CDAY) raised $420 million in an initial public offering on Thursday, April 26th 2018. The company issued 21,000,000 shares at $19.00-$21.00 per share. Goldman Sachs, J.P. Morgan, Credit Suisse and Deutsche Bank Securities acted as the underwriters for the IPO and Barclays, Citigroup, Jefferies, CIBC Capital Markets, Wells Fargo Securities, Baird, Canaccord Genuity, Piper Jaffray, William Blair and MUFG were co-managers.

Ceridian HCM trades on the New York Stock Exchange (NYSE) under the ticker symbol "CDAY."

Ceridian HCM's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Cannae Holdings Inc. (13.68%), Capital Research Global Investors (12.18%), Thomas H Lee Partners LP (8.69%), BlackRock Inc. (6.29%), Capital World Investors (4.03%) and Lone Pine Capital LLC (2.24%). Company insiders that own Ceridian HCM stock include Arthur Gitajn, Cannae Holdings, Inc, Christopher R Armstrong, David D Ossip, Lisa M Sterling, Ozzie J Goldschmied, Paul D Elliott, Scott A Kitching and Thomas H Lee Advisors, Llc. View institutional ownership trends for Ceridian HCM.

CDAY stock was sold by a variety of institutional investors in the last quarter, including Thomas H Lee Partners LP, Wellington Management Group LLP, Echo Street Capital Management LLC, Principal Financial Group Inc., Federated Hermes Inc., WINTON GROUP Ltd, Arizona State Retirement System, and BlackRock Inc.. Company insiders that have sold Ceridian HCM company stock in the last year include Arthur Gitajn, Cannae Holdings, Inc, Christopher R Armstrong, David D Ossip, Lisa M Sterling, Ozzie J Goldschmied, Scott A Kitching, and Thomas H Lee Advisors, Llc. View insider buying and selling activity for Ceridian HCM.

CDAY stock was bought by a variety of institutional investors in the last quarter, including Cannae Holdings Inc., Capital World Investors, Capital Research Global Investors, Lone Pine Capital LLC, Morgan Stanley, Morgan Stanley, Janus Henderson Group PLC, and First Trust Advisors LP. View insider buying and selling activity for Ceridian HCM.

Shares of CDAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of CDAY stock can currently be purchased for approximately $68.87.

Ceridian HCM has a market capitalization of $9.99 billion and generates $824.10 million in revenue each year. The company earns $78.70 million in net income (profit) each year or $0.26 on an earnings per share basis. Ceridian HCM employs 5,011 workers across the globe.

The official website for Ceridian HCM is www.ceridian.com.

Ceridian HCM's mailing address is 3311 EAST OLD SHAKOPEE ROAD, MINNEAPOLIS MN, 55425. The company can be reached via phone at 952-853-8100 or via email at [email protected]